Eagle Asset Management Inc. Raises Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Eagle Asset Management Inc. boosted its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 434,514 shares of the company’s stock after acquiring an additional 3,227 shares during the period. Eagle Asset Management Inc.’s holdings in Prestige Consumer Healthcare were worth $31,328,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of PBH. Evergreen Capital Management LLC boosted its position in Prestige Consumer Healthcare by 5.4% during the 2nd quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company’s stock valued at $216,000 after buying an additional 160 shares during the period. Miller Howard Investments Inc. NY boosted its position in Prestige Consumer Healthcare by 2.2% during the 2nd quarter. Miller Howard Investments Inc. NY now owns 7,762 shares of the company’s stock valued at $534,000 after buying an additional 165 shares during the period. OLD National Bancorp IN boosted its position in Prestige Consumer Healthcare by 4.4% during the 3rd quarter. OLD National Bancorp IN now owns 3,974 shares of the company’s stock valued at $287,000 after buying an additional 168 shares during the period. Huntington National Bank boosted its position in Prestige Consumer Healthcare by 39.9% during the 3rd quarter. Huntington National Bank now owns 635 shares of the company’s stock valued at $46,000 after buying an additional 181 shares during the period. Finally, EverSource Wealth Advisors LLC boosted its position in Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after buying an additional 208 shares during the period. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Stock Up 0.8 %

Shares of Prestige Consumer Healthcare stock opened at $84.85 on Friday. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.56 and a quick ratio of 2.10. The company has a 50-day moving average of $74.13 and a 200 day moving average of $70.57. The firm has a market cap of $4.19 billion, a price-to-earnings ratio of 20.64, a PEG ratio of 2.37 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 1 year low of $56.61 and a 1 year high of $85.22.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.09. The business had revenue of $283.79 million during the quarter, compared to analyst estimates of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. Prestige Consumer Healthcare’s revenue was down .9% compared to the same quarter last year. During the same period last year, the business earned $1.07 EPS. As a group, sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have commented on PBH. Jefferies Financial Group restated a “hold” rating and issued a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson restated a “buy” rating and issued a $95.00 price objective on shares of Prestige Consumer Healthcare in a report on Monday, November 11th. One research analyst has rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $83.67.

Insider Buying and Selling at Prestige Consumer Healthcare

In other news, CEO Ronald M. Lombardi sold 10,875 shares of the firm’s stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total transaction of $898,275.00. Following the sale, the chief executive officer now owns 320,952 shares of the company’s stock, valued at $26,510,635.20. This trade represents a 3.28 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Mary Beth Fritz sold 9,885 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $81.97, for a total transaction of $810,273.45. Following the sale, the senior vice president now directly owns 18,835 shares in the company, valued at approximately $1,543,904.95. The trade was a 34.42 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 38,810 shares of company stock worth $3,187,300. 1.60% of the stock is owned by corporate insiders.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.